James George to Immunologic Factors
This is a "connection" page, showing publications James George has written about Immunologic Factors.
Connection Strength
1.815
-
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94.
Score: 0.641
-
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
Score: 0.512
-
Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol. 2012 May; 87 Suppl 1:S88-91.
Score: 0.386
-
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82.
Score: 0.105
-
Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012 May; 87 Suppl 1:S12-5.
Score: 0.096
-
Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med. 2008 May; 75(5):369-75.
Score: 0.074